ArticleCellular oncology (Dordrecht, Netherlands)2019

Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosis.

Dingxie LiuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.